The cellular and molecular origins of extracellular vesicles released by the helminth pathogen, Fasciola hepatica.
Aniline Compounds
/ pharmacology
Animals
Benzylidene Compounds
/ pharmacology
Biomarkers
/ metabolism
Extracellular Vesicles
/ metabolism
Fasciola hepatica
/ enzymology
Fascioliasis
/ parasitology
Helminth Proteins
/ metabolism
Sheep
/ parasitology
Sphingomyelin Phosphodiesterase
/ antagonists & inhibitors
Excretion
Extracellular vesicle
Fasciola hepatica
Helminth
Secretion
Trematode
Journal
International journal for parasitology
ISSN: 1879-0135
Titre abrégé: Int J Parasitol
Pays: England
ID NLM: 0314024
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
22
01
2020
revised:
23
03
2020
accepted:
25
03
2020
pubmed:
23
6
2020
medline:
22
6
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
Parasitic helminths secrete extracellular vesicles (EVs) which have potent immunomodulatory effects. Whilst the cargo of EVs has been characterised for many species, we know little about the mechanisms that govern their biogenesis and release. Using antibodies raised against a panel of Fasciola hepatica EV (FhEV) marker proteins, we have identified multiple sites of EV production in the parasite. Discrete immunofluorescence patterns were observed within the gastrodermal cells and tegumental syncytium for different marker proteins whilst the protonephridial (excretory) system and parenchymal-type 2 cells were identified as additional sites of production (or transit) of FhEVs. Ligation was used to mechanically block the oral sucker, excretory pore, or both, to determine the effect on FhEV release from live adult flukes in vitro. This revealed that FhEVs are predominately derived from the gut, whilst the tegument releases EVs to a lesser extent. The data also suggest that the protonephridial system contributes to the small (120 K) EV sub-population. Sphingomyelinase (SMase) activity is a key driver of EV biogenesis in mammalian cells and we have previously identified SMases in FhEVs by mass spectrometry. SMase activity associated with isolated FhEVs was susceptible to the chemical inhibitor GW4869 and treatment of adult flukes with GW4869 led to a significant reduction in 120 K EV release in vitro, suggesting that a ceramide-dependent mechanism could drive 120 K EV formation. In contrast, the release of the larger 15 K EVs was only moderately impacted, indicating that they form independently of SMase activity. Ultrastructural observation of GW4869-treated F. hepatica tissue showed severe disruption to the parenchyma and vacuolation of the tegument, gastrodermal cells and epithelial lining of the excretory ducts. This work establishes that targeted disruption of EV biogenesis and release in helminths is possible, and provides proof-of-concept for future studies investigating EV secretion as a target for parasite control.
Identifiants
pubmed: 32569641
pii: S0020-7519(20)30147-8
doi: 10.1016/j.ijpara.2020.03.015
pii:
doi:
Substances chimiques
Aniline Compounds
0
Benzylidene Compounds
0
Biomarkers
0
GW 4869
0
Helminth Proteins
0
Sphingomyelin Phosphodiesterase
EC 3.1.4.12
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
671-683Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L019612/1
Pays : United Kingdom
Informations de copyright
Copyright © 2020 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.